More than 150 organizations have appealed to Pam Bondi, the attorney general of the United States, to bring attention to telemedicine policy under the Department of Justice’s jurisdiction. The letter – organized by the Alliance…
Continue Reading
The U.S. Drug Enforcement Agency’s proposed rule to establish special registrations for providers and telemedicine platforms to prescribe certain schedules of controlled substances without requiring an in-person doctor’s visit requires “meaningful” clarification and adjustments,…
Continue Reading
Breaking News: DEA’s Latest Regulatory Proposal
The Drug Enforcement Agency (DEA) has unveiled its proposed framework for prescribing controlled substances virtually, addressing the Ryan Haight Online Pharmacy Consumer Protection Act requirements. This announcement follows the…
The U.S. Drug Enforcement Agency has released its notice of proposed rulemaking for a framework to permit medically necessary controlled substances without an in-person visit without violating the Ryan Haight Online Pharmacy Consumer Protection…
Continue Reading
The U.S. Drug Enforcement Agency and Health and Human Services announced the Third Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications, preventing some patients from losing access to their telehealth-prescribed medications. The agencies…
Continue Reading
When the Drug Enforcement Administration (DEA) released its proposed rule that would remove some of the Covid-19 telehealth flexibilities for the prescribing of controlled substances, it caused an uproar from telehealth companies and advocates….
Continue Reading
